An investigational factor XI inhibitor shows early promise for treating atrial fibrillation in patients with a degree of kidney impairment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback